(Q44675133)

5 December 2017

More efficient mobilisation of peripheral blood stem cells with HiDAC+AMSA+G-CSF than with mini-ICE+G-CSF in patients with AML. (English)

1 reference

5 December 2017

1

Höglund M

1 reference

5 December 2017

Brune M

2

1 reference

5 December 2017

Sallerfors B

3

1 reference

5 December 2017

Ahlgren T

4

1 reference

5 December 2017

Billström R

5

1 reference

5 December 2017

Hedenus M

6

1 reference

5 December 2017

Markevärn B

7

1 reference

5 December 2017

Nilsson B

8

1 reference

5 December 2017

Simonsson B

9

1 reference

5 December 2017

Stockelberg D

10

1 reference

5 December 2017

Wahlin A

11

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Bone Marrow Transplantation

5 December 2017

1 reference

5 December 2017

32

1 reference

5 December 2017

12

1 reference

5 December 2017

1119-1124

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704294

5 December 2017

0 references

cites work

A systematic overview of chemotherapy effects in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

Peripheral blood progenitor cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

Peripheral blood stem cell mobilization for high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

Report from a Nordic workshop on CD34+ cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. Nordic Myeloma Study Group Laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

Autologous stem cell transplantation for acute myeloid leukemia in first remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the 'DIAVE' mobilizing regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantrone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

ICE, mini-ICE or high-dose hydroxyurea to mobilize Philadelphia (Ph1)-negative PBPC in chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

Effective mobilization of Philadelphia-chromosome-negative cells in chronic myelogenous leukaemia patients using a less intensive regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

Stem cell mobilisation in lymphoproliferative diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

Peripheral blood stem cell transplantation in acute myeloid leukemia: the experience of the Bordeaux Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

Broad inter‐individual variations in circulating progenitor cell numbers induced by granulocyte colony‐stimulating factor therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

Transplantation of IL-2-mobilized autologous peripheral blood progenitor cells for adults with acute myelogenous leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704294

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704294

1 reference

5 December 2017

1 reference